FI109332B - Toremifeenin liukoisia koostumuksia - Google Patents

Toremifeenin liukoisia koostumuksia Download PDF

Info

Publication number
FI109332B
FI109332B FI982734A FI982734A FI109332B FI 109332 B FI109332 B FI 109332B FI 982734 A FI982734 A FI 982734A FI 982734 A FI982734 A FI 982734A FI 109332 B FI109332 B FI 109332B
Authority
FI
Finland
Prior art keywords
toremifene
acid
base
site
lactate
Prior art date
Application number
FI982734A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI982734A (fi
FI982734A0 (fi
Inventor
Heikki Niskanen
Pirjo Kortesuo
Juha Kiesvaara
Jukka Salmia
Mikko Kananen
Leena Otsomaa
Ursin Kaija Af
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Publication of FI982734A0 publication Critical patent/FI982734A0/fi
Priority to FI982734A priority Critical patent/FI109332B/fi
Priority to DE69916888T priority patent/DE69916888T2/de
Priority to AT99963615T priority patent/ATE265230T1/de
Priority to JP2000587805A priority patent/JP2002532438A/ja
Priority to AU19856/00A priority patent/AU1985600A/en
Priority to ES99963615T priority patent/ES2220138T3/es
Priority to SI9930548T priority patent/SI1140197T1/xx
Priority to US09/868,180 priority patent/US6491951B1/en
Priority to EP99963615A priority patent/EP1140197B1/fr
Priority to PCT/FI1999/001047 priority patent/WO2000035486A1/fr
Priority to DK99963615T priority patent/DK1140197T3/da
Priority to PT99963615T priority patent/PT1140197E/pt
Publication of FI982734A publication Critical patent/FI982734A/fi
Application granted granted Critical
Publication of FI109332B publication Critical patent/FI109332B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI982734A 1998-12-17 1998-12-17 Toremifeenin liukoisia koostumuksia FI109332B (fi)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FI982734A FI109332B (fi) 1998-12-17 1998-12-17 Toremifeenin liukoisia koostumuksia
SI9930548T SI1140197T1 (en) 1998-12-17 1999-12-16 Soluble compositions of toremifene
EP99963615A EP1140197B1 (fr) 1998-12-17 1999-12-16 Compositions solubles de toremifene
JP2000587805A JP2002532438A (ja) 1998-12-17 1999-12-16 トレミフェンの水溶性組成物
AU19856/00A AU1985600A (en) 1998-12-17 1999-12-16 Soluble compositions of toremifene
ES99963615T ES2220138T3 (es) 1998-12-17 1999-12-16 Composiciones solubles de toremifeno.
DE69916888T DE69916888T2 (de) 1998-12-17 1999-12-16 Lösliche zusammensetzungen von toremifene
US09/868,180 US6491951B1 (en) 1998-12-17 1999-12-16 Soluble compositions of toremifene
AT99963615T ATE265230T1 (de) 1998-12-17 1999-12-16 Lösliche zusammensetzungen von toremifene
PCT/FI1999/001047 WO2000035486A1 (fr) 1998-12-17 1999-12-16 Compositions solubles de toremifene
DK99963615T DK1140197T3 (da) 1998-12-17 1999-12-16 Opløselige præparater med toremifen
PT99963615T PT1140197E (pt) 1998-12-17 1999-12-16 Composicoes soluveis de toremifeno

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI982734A FI109332B (fi) 1998-12-17 1998-12-17 Toremifeenin liukoisia koostumuksia
FI982734 1998-12-17

Publications (3)

Publication Number Publication Date
FI982734A0 FI982734A0 (fi) 1998-12-17
FI982734A FI982734A (fi) 2000-06-18
FI109332B true FI109332B (fi) 2002-07-15

Family

ID=8553139

Family Applications (1)

Application Number Title Priority Date Filing Date
FI982734A FI109332B (fi) 1998-12-17 1998-12-17 Toremifeenin liukoisia koostumuksia

Country Status (11)

Country Link
US (1) US6491951B1 (fr)
EP (1) EP1140197B1 (fr)
JP (1) JP2002532438A (fr)
AT (1) ATE265230T1 (fr)
AU (1) AU1985600A (fr)
DE (1) DE69916888T2 (fr)
DK (1) DK1140197T3 (fr)
ES (1) ES2220138T3 (fr)
FI (1) FI109332B (fr)
PT (1) PT1140197E (fr)
WO (1) WO2000035486A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI20030747A0 (fi) * 2003-05-19 2003-05-19 Orion Corp Toremifeenin kiteytysmenetelmä
WO2007085962A2 (fr) * 2006-01-26 2007-08-02 Pfizer Products Inc. Nouvelles compositions auxiliaires de glycolipide
HRP20211985T1 (hr) * 2017-08-25 2022-04-01 Pfizer Inc. Farmaceutska vodena formulacija koja sadrži 1-(4-{[4-(dimetilamino)piperidin-1-il]karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]ureu

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE293263C (fr)
GB2126576B (en) 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
GB8604528D0 (en) 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
DE4013696A1 (de) 1989-05-05 1990-11-08 Asta Pharma Ag Salze des azelastins mit verbesserter loeslichkeit
US5189212A (en) 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
GB9126209D0 (en) 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4407742C1 (de) 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
DK0906243T4 (da) 1996-05-29 2009-06-08 Delsitech Oy Oplöselige oxider til biologiske anvendelser
IL122025A (en) 1996-10-30 2003-01-12 Lilly Co Eli Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer
US6114395A (en) 1996-11-15 2000-09-05 Pfizer Inc. Method of treating atherosclerosis
ES2174388T3 (es) 1997-06-27 2002-11-01 Akzo Nobel Nv Solucion liquida de medicamento para administracion oral.

Also Published As

Publication number Publication date
EP1140197B1 (fr) 2004-04-28
US6491951B1 (en) 2002-12-10
EP1140197A1 (fr) 2001-10-10
DE69916888T2 (de) 2005-04-28
FI982734A (fi) 2000-06-18
DK1140197T3 (da) 2004-05-24
JP2002532438A (ja) 2002-10-02
ES2220138T3 (es) 2004-12-01
AU1985600A (en) 2000-07-03
PT1140197E (pt) 2004-08-31
FI982734A0 (fi) 1998-12-17
WO2000035486A1 (fr) 2000-06-22
ATE265230T1 (de) 2004-05-15
DE69916888D1 (de) 2004-06-03

Similar Documents

Publication Publication Date Title
CH630260A5 (fr) Compositions antibiotiques a base d'une tetracycline.
NO335103B1 (no) Forbindelse, farmasøytisk preparat inneholdende forbindelsen, anvendelse av forbindelsen samt fremgangsmåte for fremstilling derav
CA1306261C (fr) 1,4-dihydropyridines, leur procede de preparation et leur application comme medicaments
FI109332B (fi) Toremifeenin liukoisia koostumuksia
EP2195292A1 (fr) Forme amorphe stable de dihydrogène phosphate de carvedilol avec agent stabilisant
CN107188799B (zh) 芬布芬共晶及其制备方法与应用
PL170495B1 (en) Method of obtaining a pharmaceutic agent containing sparfloxacine salt in aqueous solution
EP1140196B1 (fr) solutions pharmaceutiques comprenant des anti-oestrogènes de la classe des triphényléthylènes
MXPA01013369A (es) Nuevo proceso para la purificacion de impurezas de aldehido.
EP1883392A2 (fr) Procede de preparation d'une injection aqueuse isotonique de ropivacaine
CN113603806B (zh) 一种基于右旋糖酐修饰的胱氨酰胺衍生物、其制备及应用
CN110372635B (zh) 氢溴酸沃替西汀α晶型的制备方法
CN101701031A (zh) 一种多肽缩合剂及其合成方法
KR900014305A (ko) 소염제로서의 나프탈렌메탄아미노 유도체의 용도 및 이를 함유한 약학 조성물
US8044223B2 (en) Crystalline 19-norsteroids
JP5498862B2 (ja) カルボキシル基とアミド基を有する化合物及びその応用
Gardner et al. The synthesis of compounds for the chemotherapy of tuberculosis. II. Hydroxamic acid derivatives
EP3852878B1 (fr) Nouveau sel de dicyclanil avec sulfonate de dodecylbenzene, procédé de préparation d'un tel sel, compositions contenant un tel sel, et utilisation d'un tel sel pour combattre des parasites
WO2007138462A2 (fr) Formulations orales aqueuses de rispéridone
MXPA04011736A (es) Procedimiento para la obtencion de modificaciones cristalinas especificas de substancias polimeras.
BG63046B1 (bg) Пиролидинилметилиндолова сол
KR20090015649A (ko) 덱시부프로펜염의 제조방법
WO2005000780A1 (fr) Sels de piperazine des acides hydroxycinnamiques et des hydroxystilbenes
EP2142532A1 (fr) Nouveau camsilate d'imatinib et son procédé de préparation
BE528022A (fr)